- Home
- PRAX vs ALEX Comparison
PRAX vs ALEX Comparison
Compare PRAX & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- ALEX
- Stock Information
- Founded
- PRAX 2015
- ALEX 1870
- Country
- PRAX United States
- ALEX United States
- Employees
- PRAX N/A
- ALEX N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- ALEX Real Estate Investment Trusts
- Sector
- PRAX Health Care
- ALEX Real Estate
- Exchange
- PRAX Nasdaq
- ALEX Nasdaq
- Market Cap
- PRAX 1.5B
- ALEX 1.3B
- IPO Year
- PRAX 2020
- ALEX N/A
- Fundamental
- Price
- PRAX $70.54
- ALEX $17.54
- Analyst Decision
- PRAX Strong Buy
- ALEX Buy
- Analyst Count
- PRAX 9
- ALEX 3
- Target Price
- PRAX $146.33
- ALEX $22.50
- AVG Volume (30 Days)
- PRAX 309.5K
- ALEX 427.9K
- Earning Date
- PRAX 03-04-2025
- ALEX 02-26-2025
- Dividend Yield
- PRAX N/A
- ALEX 5.09%
- EPS Growth
- PRAX N/A
- ALEX N/A
- EPS
- PRAX N/A
- ALEX 0.61
- Revenue
- PRAX $1,605,000.00
- ALEX $230,949,000.00
- Revenue This Year
- PRAX N/A
- ALEX N/A
- Revenue Next Year
- PRAX N/A
- ALEX $2.08
- P/E Ratio
- PRAX N/A
- ALEX $21.40
- Revenue Growth
- PRAX N/A
- ALEX 1.30
- 52 Week Low
- PRAX $33.01
- ALEX $15.53
- 52 Week High
- PRAX $86.93
- ALEX $20.30
- Technical
- Relative Strength Index (RSI)
- PRAX 46.51
- ALEX 42.21
- Support Level
- PRAX $60.07
- ALEX $16.86
- Resistance Level
- PRAX $71.21
- ALEX $17.82
- Average True Range (ATR)
- PRAX 4.07
- ALEX 0.31
- MACD
- PRAX -0.79
- ALEX 0.07
- Stochastic Oscillator
- PRAX 49.11
- ALEX 70.10
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc operates in the real estate sector. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces and also urban ground leases in Hawaii, thereby accounting for majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.